SOPHiA GENETICS Reports Fourth Quarter and Year End 2022 Financial Results

Mar 7 2023
Fourth Quarter Revenue Growth Accelerates; Operating Losses Notably Moderate BOSTON & LAUSANNE, Switzerland --(BUSINESS WIRE)--Mar. 7, 2023-- SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today announced financial results for its fourth quarter and full

Read more

Build something bigger than your career

Enjoyed learning about life at SOPHiA from our blogs? Here are a few of our open roles

Title Country Department
Sales Executive / Senior Sales Executive United Kingdom Clinical Sales
Strategic Account Manager - JAPAN Japan Clinical Sales
BioPharma Business Development Expert / Manager Switzerland BioPharma Sales
Junior Sales Operations Specialist Intern France Clinical Sales
Junior Bioinformation Intern - Tertiary Analysis Switzerland Data Science